Skip to main content
Log in

Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Objective: The objective of this analysis was to determine if there were differences in ventricular reverse remodeling and 6-month outcome with cardiac resynchronization therapy (CRT) among specific subgroups enrolled in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study.

Background: Analysis of major subgroups receiving CRT is important in determining who may be most likely to benefit, since all patients who receive CRT do not demonstrate improvement.

Methods: Differences in response to CRT between subgroups based on baseline echocardiographic parameters, New York Heart Association (NYHA) class, age, gender, beta blocker use, and etiology of heart failure (HF) were analyzed for the clinical end points of the study as well as 6-month HF re-hospitalization or death.

Results: The benefit of CRT over control was similar in all subgroups with respect to all clinical endpoints. However, non-ischemic HF patients had greater improvements with CRT compared to ischemic HF patients in left ventricular end diastolic volume (P < 0.001) and ejection fraction (EF) (6.7% increase vs. 3.2% [P < 0.001]). Greater improvements in EF were also seen in those patients with less severe baseline mitral regurgitation (MR) (P < 0.001). Women but not men receiving CRT were more likely to be event-free from first HF hospitalization or death compared to the control group (Hazard Ratio = 0.157).

Conclusions: The benefits of CRT with respect to EF and reverse remodeling were greater in patients with non-ischemic HF and less severe MR. Women may also derive more benefit than men with respect to the occurrence of HF hospitalization or death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–1853.

    Google Scholar 

  2. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, León AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MRS. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985–1990.

    Google Scholar 

  3. Porciani MC, Puglisi A, Colella A, Peraldo C, Gaita F, Romano M, Pistis G, Curnis A, Sabini A, Musilli N, Paeletti L, on behalf of the InSync Italian Registry Investigators. Echocardiographic evaluation of the effect of biventricular pacing: The InSync Italian Registry. Eur Heart J 2000;Suppl J(2):J23–J30.

  4. Kerwin WF, Botvinick EH, O’Connell W, Merrick SH, DeMarco T, Chatterjee K, Shciebly K, Saxon LA. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35:1221–1227.

    Article  CAS  PubMed  Google Scholar 

  5. Leclercq C, Cazeau S, Ritter P, Alonso C, Gras D, Mabo P, Lazarus A, Daubert JC. A Pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140(6):862–870.

    Article  Google Scholar 

  6. Etienne Y, Mansourati J, Touiza A, Gilard M, Bertault-Valls V, Guillo P, Boschat J, Blanc JJ. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure. Eur J Heart Fail 2001;3:441–447.

    Google Scholar 

  7. Gasparini M, Mantica M, Galimberti P, Genovese L, Pini D, Faletra F, Marchesina UL, Mangiavacchi M, Klersy C, Gronda E. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003;26(Pt II):175–180.

    Google Scholar 

  8. Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, Berger RD, McVeigh, ER, Kass DA. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000;101:2703–2709.

    Google Scholar 

  9. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E, for the VIGOR Congestive Heart Failure Investigators. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304–1310.

    Google Scholar 

  10. Stellbrink C, Breithardt O, Franke A, Sack S, Bakker P, Auricchio A, on behalf of PATH-CHF Investigators, Pochet T, Salo R, Kramer A, Spinelli J. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957–1965.

    Google Scholar 

  11. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M, Clementy J. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002;89:346–350.

    Google Scholar 

  12. Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 1988;62:25A–30A.

    Google Scholar 

  13. Cohn J, Johnson G, the Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: The V-HeFT study. Circulation 1990;(81 Suppl III)(III):48–53.

  14. Ghali J, Kadakia S, Bhatt A, Cooper R, Liao Y. Survival of heart failure patients with preserved versus impaired systolic function: The prognostic implication of blood pressure. Am Heart J 1992;123:993–997.

    Google Scholar 

  15. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DeCarlo L, DeMets D, White BG, DeVries DW, Feldman AM for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–2150.

    Google Scholar 

  16. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, Menapace Jr. FJ, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E. Acute Myocardial Infarction/Antiplatelet and Thrombolytic Therapy: Quantitative Two-Dimensional Echocardiographic Measurements Are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effects of Captopril. Circulation 1994;89(1):68–75.

    Google Scholar 

  17. Norris RM, White HD, Cross DB, Wild CJ, Whitlock RM. Prognosis after recovery from myocardial infarction: The relative importance of cardiac dilatation and coronary stenoses. Eur Heart J 1992;13:1611–1618.

    Google Scholar 

  18. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993;72:672–676.

    Google Scholar 

  19. Lau CP, Yu CM, Chau E, Fan K, Tse HF, Lee K, Tang MO, Wan SH, Law TC, Lee PY, Lam YM, Hill MR. Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure. Pacing Clin Electrophysiol 2000;23(Pt II):1722–1725.

    Google Scholar 

  20. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003;91:684–688.

    Google Scholar 

  21. Levine TB, Levine AB, Bolenbaugh J, Stomel RJ. Impact of left ventricular size on pharmacologic reverse remodeling in heart failure. Clin Cardiol 2000;23:355–358.

    Google Scholar 

  22. Lamas GA, Mitchell GF, Faker GC, Smith Jr. SC, Gersh BJ, Basta L, Moye L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997;96:827–833.

    Google Scholar 

  23. Tada H, Tamai J, Takaki H, Ohnishi E, Okano Y, Yoshioka T. Mild mitral regurgitation reduces exercise capacity in patients with idiopathic dilated cardiomyopathy. Int J Cardiol 1997;58:41–45.

    Google Scholar 

  24. Pozzoli M, Capomolla S, Pinna G. Doppler Echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 1996;27:883–893.

    Google Scholar 

  25. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355–359.

    Google Scholar 

  26. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, Guerrero JL, Vlahakes GJ, Levine RA. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96:1999–2008.

    Google Scholar 

  27. Breithardt OA, Stellbrink C, Kramer AP, Sinha AM, Franke A, Salo R, Schiffgens B, Huvelle E, Auricchio A. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:536–545.

    Google Scholar 

  28. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765–770.

    Google Scholar 

  29. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA 2003;89:730–740.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory W. Woo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woo, G.W., Petersen-Stejskal, S., Johnson, J.W. et al. Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study. J Interv Card Electrophysiol 12, 107–113 (2005). https://doi.org/10.1007/s10840-005-6545-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-005-6545-3

Key words

Navigation